Genetic evaluation of pediatric pituitary adenomas and USP8-related genotype-phenotype correlations in Cushing's disease.
Rida Zainab, Sukhvir Kaur, Justin Lack...
https://pubmed.ncbi.nlm.nih.gov/40813536/Actively Recruiting
Led by National Institute of Allergy and Infectious Diseases (NIAID) · Updated on 2026-11-02
20000
Participants Needed
2
Research Sites
N/A
Total Duration
Researchers are studying genetic factors involved in immune disorders such as atopy, primary immunodeficiency, autoimmunity, and autoinflammation. The goal is to better understand the genetics of these conditions and evaluate clinical genomics and genetic counseling services. This observational study focuses on detailed analysis of DNA sequencing to uncover genetic differences that may impact health and medical care. Participants include probands enrolled in other NIH protocols or referred from specific genetic studies, as well as their biological relatives and some healthy volunteers. DNA samples from blood, saliva, or other tissues will be collected and analyzed using next-generation sequencing technologies. The study involves standardized genetic testing procedures, clinical interpretation, and genetic counseling, with data shared among research teams when participants are enrolled in multiple protocols. Participants will provide samples and may complete surveys and interviews if able. Researchers will measure genetic defects and clinical phenotypes related to immune disorders by analyzing genomic data. Results important to health and confirmed clinically will be returned to participants. Data and samples will be stored for future research with privacy protections in place. The study may contact participants if new information is needed, and participation may last for many years as data collection continues.
CONDITIONS
NIAID Centralized Sequencing Protocol
M
Morgan N Similuk
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
National Institute of Allergy and Infectious Diseases (NIAID)
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote) for eligibility assessment
Duration - Varies by participant
Participants provide biological samples such as blood, saliva, or other tissue for DNA analysis using next-generation sequencing technologies.
One or more sample collection visits
Duration - Ongoing throughout study participation
Researchers analyze DNA data to identify genetic defects and clinical features related to immune disorders and provide genetic counseling based on results.
Periodic follow-ups for results and counseling
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Rida Zainab, Sukhvir Kaur, Justin Lack...
https://pubmed.ncbi.nlm.nih.gov/40813536/Elise M N Ferré, Yunting Yu, Vasileios Oikonomou...
https://pubmed.ncbi.nlm.nih.gov/36875114/Breanna J Beers, Morgan N Similuk, Rajarshi Ghosh...
https://pubmed.ncbi.nlm.nih.gov/37215141/Morgan N Similuk, Jia Yan, Rajarshi Ghosh...
https://pubmed.ncbi.nlm.nih.gov/35753512/National Institute of Allergy and Infectious Diseases (NIAID)
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborating Sponsor